Gizelle Popradi

Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from unrelated donors: a randomised, controlled, open-label, phase 3, multicentre trial

Irwin Walker, Tony Panzarella, Stephen Couban et al. · The Lancet Oncology · 2015 · 363 citations

Medicine, Hematology, Immunology +17

Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial

Irwin Walker, Tony Panzarella, Stephen Couban et al. · The Lancet Haematology · 2020 · 96 citations

Life Sciences, Hematology, Immunology +12

Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells

Amina Kariminia, Shernan G. Holtan, Sabine Ivison et al. · Blood · 2016 · 93 citations · Full text

Life Sciences, Cell Biology, Immunology +12

Multiple myeloma epidemiology and patient geographic distribution in Canada: A population study

Matthew Tsang, Michelle Le, Feras M. Ghazawi et al. · Cancer · 2019 · 68 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Analysis of acute myeloid leukemia incidence and geographic distribution in Canada from 1992 to 2010 reveals disease clusters in Sarnia and other industrial US border cities in Ontario

Feras M. Ghazawi, Michelle Le, Janelle Cyr et al. · Cancer · 2019 · 51 citations

Medicine, Health Sciences, Oncology +17